Ahn-Gook Pharmaceutical Full Year 2023 Earnings EPS 114 - Simply Wall St

149980 Stock  KRW 6,700  100.00  1.47%   
About 61% of Hironic Co's investor base is looking to short. The analysis of current outlook of investing in Hironic Co suggests that many traders are alarmed regarding Hironic Co's prospects. The current market sentiment, together with Hironic Co's historical and current headlines, can help investors time the market. In addition, many technical investors use Hironic Co stock news signals to limit their universe of possible portfolio assets.
  
Ahn-Gook Pharmaceutical Full Year 2023 Earnings EPS 114 Simply Wall St

Read at news.google.com
Google News at Macroaxis
  

Hironic Co Fundamental Analysis

We analyze Hironic Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hironic Co using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hironic Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Return On Asset

Return On Asset Comparative Analysis

Hironic is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Hironic Co Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hironic Co stock to make a market-neutral strategy. Peer analysis of Hironic Co could also be used in its relative valuation, which is a method of valuing Hironic Co by comparing valuation metrics with similar companies.

Complementary Tools for Hironic Stock analysis

When running Hironic Co's price analysis, check to measure Hironic Co's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hironic Co is operating at the current time. Most of Hironic Co's value examination focuses on studying past and present price action to predict the probability of Hironic Co's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hironic Co's price. Additionally, you may evaluate how the addition of Hironic Co to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
CEOs Directory
Screen CEOs from public companies around the world